167 related articles for article (PubMed ID: 33887677)
1. Selection of individuals for lung cancer screening based on risk prediction model performance and economic factors - The Ontario experience.
Tammemägi MC; Darling GE; Schmidt H; Llovet D; Buchanan DN; Leung Y; Miller B; Rabeneck L
Lung Cancer; 2021 Jun; 156():31-40. PubMed ID: 33887677
[TBL] [Abstract][Full Text] [Related]
2. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
3. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
[TBL] [Abstract][Full Text] [Related]
4. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
5. Analysis of lung cancer risk model (PLCO
Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the accuracy of the PLCO
Jantzen R; Ezer N; Camilleri-Broët S; Tammemägi MC; Broët P
CMAJ Open; 2023; 11(2):E314-E322. PubMed ID: 37041013
[TBL] [Abstract][Full Text] [Related]
7. LDCT lung cancer screening in populations at different risk for lung cancer.
Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
[TBL] [Abstract][Full Text] [Related]
8. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG
Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694
[TBL] [Abstract][Full Text] [Related]
10. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
11. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
Hüsing A; Kaaks R
Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland.
Tomonaga Y; de Nijs K; Bucher HC; de Koning H; Ten Haaf K
Int J Cancer; 2024 Feb; 154(4):636-647. PubMed ID: 37792671
[TBL] [Abstract][Full Text] [Related]
13. Organized Lung Cancer Screening Pilot: Informing a Province-Wide Program in Ontario, Canada.
Darling GE; Tammemägi MC; Schmidt H; Buchanan DN; Leung Y; McGarry C; Rabeneck L
Ann Thorac Surg; 2021 Jun; 111(6):1805-1811. PubMed ID: 33039364
[TBL] [Abstract][Full Text] [Related]
14. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.
Ten Haaf K; Bastani M; Cao P; Jeon J; Toumazis I; Han SS; Plevritis SK; Blom EF; Kong CY; Tammemägi MC; Feuer EJ; Meza R; de Koning HJ
J Natl Cancer Inst; 2020 May; 112(5):466-479. PubMed ID: 31566216
[TBL] [Abstract][Full Text] [Related]
15. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of using risk models for eligibility selection to the International lung screening Trial.
Cressman S; Weber MF; Ngo PJ; Wade S; Behar Harpaz S; Caruana M; Tremblay A; Manser R; Stone E; Atkar-Khattra S; Karikios D; Ho C; Fernandes A; Yi Weng J; McWilliams A; Myers R; Mayo J; Yee J; Yuan R; Marshall HM; Fong KM; Lam S; Canfell K; Tammemägi MC
Lung Cancer; 2023 Feb; 176():38-45. PubMed ID: 36592498
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
18. Selecting lung cancer screenees using risk prediction models-where do we go from here.
Tammemägi MC
Transl Lung Cancer Res; 2018 Jun; 7(3):243-253. PubMed ID: 30050763
[TBL] [Abstract][Full Text] [Related]
19. Assessing Different Approaches to Leveraging Historical Smoking Exposure Data to Better Select Lung Cancer Screening Candidates: A Retrospective Validation Study.
Kats DJ; Adie Y; Tlimat A; Greco PJ; Kaelber DC; Tarabichi Y
Nicotine Tob Res; 2021 Aug; 23(8):1334-1340. PubMed ID: 32974635
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
